Late-onset Huntington's disease: Diagnostic and prognostic considerations
Tài liệu tham khảo
Roos, 2010, Huntington's disease: a clinical review, Orphanet J Rare Dis, 5, 40, 10.1186/1750-1172-5-40
Koutsis, 2013, The challenge of juvenile Huntington disease: to test or not to test, Neurology, 80, 990, 10.1212/WNL.0b013e31828727fa
Shulman, 1996, Late-onset Huntington's disease: a geriatric psychiatry perspective, J Geriatr Psychiatry Neurol, 9, 26, 10.1177/089198879600900105
Foroud, 1999, Differences in duration of Huntington's disease based on age at onset, J Neurol Neurosurg Psychiatry, 66, 52, 10.1136/jnnp.66.1.52
Rosenblatt, 2012, Age, CAG repeat length and clinical progression in Huntington's disease, Mov Disord, 27, 272, 10.1002/mds.24024
Myers, 1985, Late onset of Huntington's disease, J Neurol Neurosurg Psychiatry, 48, 530, 10.1136/jnnp.48.6.530
Kremer, 1993, Molecular analysis of late onset Huntington's disease, J Med Genet, 30, 991, 10.1136/jmg.30.12.991
James, 1994, Late-onset Huntington's disease: a clinical and molecular study, Age Ageing, 23, 445, 10.1093/ageing/23.6.445
Lipe, 2009, Late onset Huntington disease: clinical and genetic characteristics of 34 cases, J Neurol Sci, 276, 159, 10.1016/j.jns.2008.09.029
Shoulson, 1979, Huntington disease: clinical care and evaluation, Neurology, 29, 1, 10.1212/WNL.29.1.1
Markianos, 2005, Plasma testosterone in male patients with Huntington’s disease: relations to severity of illness and dementia, Ann Neurol, 57, 520, 10.1002/ana.20428
Warner, 1993, A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes, Mol Cell Probes, 7, 235, 10.1006/mcpr.1993.1034
Adams, 1988, Huntington disease in Georgia: age at onset, Am J Hum Genet, 43, 695
Morrison, 1995, The epidemiology of Huntington's disease in Northern Ireland, J Med Genet, 32, 524, 10.1136/jmg.32.7.524
Panas, 2011, Huntington's disease in Greece: the experience of 14 years, Clin Genet, 80, 586, 10.1111/j.1399-0004.2010.01603.x
Harbo, 2009, EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington’s disease, Parkinson's disease and dystonias, Eur J Neurol, 16, 777, 10.1111/j.1468-1331.2009.02646.x
Kremer, 1994, A worldwide study of the Huntington's disease mutation, N Engl J Med, 330, 1401, 10.1056/NEJM199405193302001
Rubinsztein, 1994, Study of the Huntington's disease (HD) gene CAG repeats in schizophrenic patients shows overlap of the normal and JD affected ranges but absence of correlation with schizophrenia, J Med Genet, 31, 690, 10.1136/jmg.31.9.690
Wang, 2010, Testing and interval estimation for two sample comparisons with small samples and unequal censoring, Biostatistics, 11, 676, 10.1093/biostatistics/kxq021
Pillai, 2012, Clinical severity of Huntington's disease does not always correlate with neuropathological stage, Mov Disord, 27, 1099, 10.1002/mds.25026